论文部分内容阅读
目的研究急性冠脉综合征支架置入术后应用血脂康调脂及预防再狭窄的作用。方法对通化市人民医院2001-01~2003-01安置冠脉内支架的冠心病患者,分辛伐他汀治疗组及血脂康治疗组,所有患者均由股动脉穿刺途径以Judkin s法完成冠状动脉造影检查,以1支血管管腔狭窄≥70%定为有意义的狭窄病变,进行支架置入术,12个月时再次进行冠状动脉造影检查。结果血脂康治疗及辛伐他汀治疗组在性别、年龄、血压、糖尿病等方面差异无统计学意义。两组病人的冠脉造影病变的特征差异无统计学意义。经过12个月的随访观察,两组的降血脂作用和预防再狭窄的程度相似。结论应用辛伐他汀和血脂康治疗后使血脂浓度明显降低,介入治疗后血脂康与辛伐他汀预防再狭窄作用相似。
Objective To study the effect of Xuezhikang liposuction and prevention of restenosis after stenting of acute coronary syndromes. Methods To investigate the coronary heart disease patients treated with coronary stents in the Tonghua Municipal People’s Hospital from January 2001 to January 2003, the patients treated with simvastatin and Xuezhikang, all patients underwent coronary angiography Contrast angiography, with 1 vessel stenosis ≥ 70% as a meaningful stenosis, stent placement, 12 months, coronary angiography again. Results Xuezhikang treatment and simvastatin treatment group in gender, age, blood pressure, diabetes and other aspects no significant difference. There was no significant difference in the characteristics of coronary angiography between the two groups of patients. After 12 months of follow-up observation, the two groups of lipid-lowering effect and prevention of restenosis to a similar extent. Conclusion Serum lipid concentrations were significantly decreased after treatment with simvastatin and Xuezhikang, and the effects of Xuezhikang and simvastatin on restenosis were similar after interventional therapy.